Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Filarial Lymphedema (LeDoxy-SL)
NCT02929134Phase 3Completed
- Sponsor
- Task Force for Global Health
- Start
- Feb 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lymphedema comparing Doxycycline with Placebo (2 arms). Primary endpoint: Change in Lymphedema Grade at 24 months. Started Feb 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT02929134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929134.